Alnylam Pharmace. buy Stifel Nicolaus
Summary
This prediction ended on 15.09.24 with a price of €240.20. The BUY prediction by Stifel_Nicolaus for Alnylam Pharmace. saw massive gains of 32.41%. Stifel_Nicolaus has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Stifel_Nicolaus has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -1.169% | -1.169% | 48.160% |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% |
Comments by Stifel_Nicolaus for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
31.03.25
31.03.26
23.12.25
Stopped prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
11.12.25
11.12.26
23.12.25
Alnylam Pharmace.
06.10.25
06.10.26
23.12.25
Alnylam Pharmace.
27.06.24
27.06.25
28.06.25

